The U.S. Federal Reserve announced Wednesday that it will keep its benchmark interest rate unchanged at around 5.3%, signaling a…
Read More »
CRISPR Therapeutics (NASDAQ: CRSP) saw a notable increase in its stock price, rising by 3.6% even though there was no…
Read More »
The European Central Bank (ECB) has reduced its main interest rate for the first time in five years, from a…
Read More »
In a move that reflects both the domestic economic landscape and broader global trends, the Bank of Canada (BoC) is…
Read More »
A New York jury found former President Donald Trump guilty on 34 felony counts of falsifying business records to cover…
Read More »
As the tobacco industry faces increasing regulatory scrutiny and changing consumer preferences, the major players are pivoting towards reduced-risk nicotine…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Jordan R. Plews, PhD has…
Read More »
In a groundbreaking move, Donald J. Trump’s 2024 presidential campaign has announced it will accept cryptocurrency donations, marking the first…
Read More »
The recent approval by the U.S. Securities and Exchange Commission (SEC) of spot Ethereum exchange-traded funds (ETFs) marks a significant…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…
Read More »